Schedule 13D ownership disclosure

NAVIDEA BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 63937X202

Event date: 2023-06-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
75.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-077719
Form type
SC 13D/A
Filer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK
CIK 810509
Filed
Jul 05, 2023
Reporting period
Jun 29, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub